Scolaris Content Display Scolaris Content Display

Yoga para el tratamiento de la incontinencia urinaria en mujeres

Contraer todo Desplegar todo

Referencias

Referencias de los estudios incluidos en esta revisión

Baker 2014 {published and unpublished data}

Baker J, Costa D, Guarino JM, Nygaard I. Comparison of mindfulness‐based stress reduction versus yoga on urinary urge incontinence: a randomized pilot study with 6‐month and 1‐year follow‐up visits. Female Pelvic Medicine & Reconstructive Surgery 2014;20(3):141‐6. [sr‐incont60609; PUBMED: 24763155]CENTRAL
NCT01470560. Mindfulness‐based stress reduction techniques and yoga for treatment of urinary urge incontinence (MBSR‐Yoga). clinicaltrials.gov/ct2/show/NCT01470560 (first received 11 November 2011). [sr‐incont49230]CENTRAL

Huang 2014a {published data only}

Huang AJ, Chesney MA, Schembri M, Subak LL. Yoga to treat urinary incontinence in women: results of a pilot randomized trial. Female Pelvic Medicine & Reconstructive Surgery 2013;19(5 Suppl):S72‐3. [sr‐incont72783]CENTRAL
Huang AJ, Jenny HE, Chesney MA, Schembri M, Subak LL. A group‐based yoga therapy intervention for urinary incontinence in women: a pilot randomized trial. Female Pelvic Medicine & Reconstructive Surgery 2014;20(3):147‐54. [sr‐incont60608; PUBMED: 24763156]CENTRAL
Huang AJ, Jenny HE, Chesney MA, Schembri M, Subak LL. Yoga for urinary incontinence in middle‐aged and older women: results of a pilot randomized trial. Journal of General Internal Medicine 2014;29(1 Suppl):S261. [Abstract: Tracking ID #1926774; sr‐incont61847]CENTRAL
Jenny HE, Subak LL, Chesney MA, Schembri M, Huang AJ. Yoga for urinary incontinence in middle‐aged and older women: results of a pilot randomized trial. Journal of the American Geriatrics Society 2014;62(Suppl s1):S98. [Abstract number B27; sr‐incont61850]CENTRAL
NCT01672190. Lessening incontinence by learning yoga (LILY). clinicaltrials.gov/ct2/show/NCT01672190 (first received 24 August 2012). [sr‐incont49228]CENTRAL

Referencias de los estudios excluidos de esta revisión

Burgio 2003 {published data only}

Burgio KL, Goode PS, Locher JL, Richter HE, Roth DL, Wright KC, et al. Predictors of outcome in the behavioral treatment of urinary incontinence in women. Obstetrics and Gynecology 2003;102(5 Pt 1):940‐7. [sr‐incont17367; PUBMED: 14672467]CENTRAL

Burgio 2006 {published data only}

Burgio KL, Goode PS, Richter HE, Locher JL, Roth DL. Global ratings of patient satisfaction and perceptions of improvement with treatment for urinary incontinence: validation of three global patient ratings. Neurourology and Urodynamics 2006;25(5):411‐7. [sr‐incont22346; PUBMED: 16652380]CENTRAL

Felsted 2017 {published data only}

Felsted K, NCT03176901. Comparing approaches to treat older adult women's urge incontinence: pilot feasibility and randomized controlled trial (SHUW) [Comparing mindfulness‐based stress reduction with the health enhancement program in the treatment of urinary urge incontinence in older adult women: a pilot feasibility and randomized controlled trial]. clinicaltrials.gov/show/NCT03176901 (first received 6 June 2017). [NCT03176901; sr‐incont76187]CENTRAL

Wein 2015 {published data only}

Wein AJ. Re: A group‐based yoga therapy intervention for urinary incontinence in women: a pilot randomized trial. Journal of Urology2015; Vol. 193, issue 4:1313. [PUBMED: 25890531]CENTRAL

Wells 1999 {unpublished data only}

Wells T, Mayer R, Brink C, Brown R. Pelvic muscle exercise: a controlled clinical trial [notification of unpublished manuscript via personal communication]. Email to: Jean Hay‐Smith. 3 November 2008. [sr‐incont26977]CENTRAL

Referencias de los estudios en espera de evaluación

Huang 2018 {unpublished data only}

Huang A, Chesney M, Schembri M, Subak L. A randomized trial of a group‐based therapeutic yoga program for ambulatory women with urinary incontinence. Journal of Urology 2018;199(4 Suppl):e645. [DOI: 10.1016/j.juro.2018.02.1544; Abstract number PD32‐01; sr‐incont77829]CENTRAL
NCT02342678. Lessening incontinence through low‐impact activity (LILA) [Lessening incontinence through low‐impact activity, a.k.a. yoga to enhance behavioral self‐management of urinary incontinence in women]. clinicaltrials.gov/ct2/show/NCT02342678 (first received 21 January 2015). [sr‐incont67528]CENTRAL

Abrams 2013

Abrams P, Andersson KE, Artibani W, Birder I, Bliss D, Brubaker L, et al. Recommendations of the International Scientific Committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse and faecal incontinence. Incontinence: 5th International Consultation on Incontinence. Paris: ICUD‐EAU 2013, 2013:1895‐945.

AHRQ 2018

Balk E, Adam GP, Kimmel H, Rofeberg V, Saeed I, Jeppson P, et al. Nonsurgical treatments for urinary incontinence in women: a systematic review update. Rockville (MD): Agency for Healthcare Research and Quality (AHRQ); 2018 August. Comparative Effectiveness Review No. 212. (Prepared by the Brown Evidence‐based Practice Center under Contract No. 290‐2015‐00002‐I for AHRQ and PCORI.) AHRQ Publication No.: 18‐EHC016‐EF. PCORI Publication No.: 2018‐SR‐03. Available at effectivehealthcare.ahrq.gov/topics/urinary‐incontinence‐update/final‐report‐2018. [DOI: 10.23970/AHRQEPCCER212]

Ayeleke 2015

Ayeleke RO, Hay‐Smith EJ, Omar MI. Pelvic floor muscle training added to another active treatment versus the same active treatment alone for urinary incontinence in women. Cochrane Database of Systematic Reviews 2015, Issue 11. [DOI: 10.1002/14651858.CD010551.pub3; PUBMED: 26526663]

Barber 2001

Barber MD, Kuchibhatla MN, Pieper CF, Bump RC. Psychometric evaluation of 2 comprehensive condition‐specific quality of life instruments for women with pelvic floor disorders. American Journal of Obstetrics and Gynecology 2001;185(6):1388‐95. [PUBMED: 11744914]

Bø 2000

Bø K, Berghmans LC. Nonpharmacologic treatments for overactive bladder ‐ pelvic floor exercises. Urology 2000;55(5A Suppl):7‐11; discussion 14‐6. [PUBMED: 10767443]

Bø 2004

Bø K. Pelvic floor muscle training is effective in treatment of female stress urinary incontinence, but how does it work?. International Urogynecology Journal and Pelvic Floor Dysfunction 2004;15(2):76‐84. [PUBMED: 15014933]

Bø 2013

Bø K, Herbert RD. There is not yet strong evidence that exercise regimens other than pelvic floor muscle training can reduce stress urinary incontinence in women: a systematic review. Journal of Physiotherapy 2013;59(3):159‐68. [PUBMED: 23896331]

Bø 2017

Bø K, Frawley HC, Haylen BT, Abramov Y, Almeida FG, Berghmans B, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for the conservative and nonpharmacological management of female pelvic floor dysfunction. International Urogynecology Journal 2017;28(2):191‐213. [PUBMED: 27921161]

Cannon 2004

Cannon TW, Damaser M. Pathophysiology of the lower urinary tract: continence and incontinence. Clinical Obstetrics and Gynecology 2004;47(1):28‐35. [PUBMED: 15024270]

Clarke 2015

Clarke TC, Black LI, Stussman BJ, Barnes PM, Nahin RL. Trends in the use of complementary health approaches among adults: United States, 2002‐2012. Hyattsville (MD): National Center for Health Statistics. National Health Statistics Reports; no. 79. www.cdc.gov/nchs/data/nhsr/nhsr079.pdf (accessed 14 May 2018).

Covidence 2017 [Computer program]

Veritas Health Innovation. Covidence. Version accessed 26 June 2018. Melbourne, Australia: Veritas Health Innovation, 2017.

Cramer 2013

Cramer H, Krucoff C, Dobos G. Adverse events associated with yoga: a systematic review of published case reports and case series. PLoS ONE 2013;8(10):e75515.

Cramer 2015

Cramer H, Ward L, Saper R, Fishbein D, Dobos G, Lauche R. The safety of yoga: a systematic review and meta‐analysis of randomized controlled trials. American Journal of Epidemiology 2015;182(4):281‐93. [PUBMED: 26116216]

Cramer 2016

Cramer H, Ward L, Steel A, Lauche R, Dobos G, Zhang Y. Prevalence, patterns, and predictors of yoga use: results of a U.S. nationally representative survey. American Journal of Preventive Medicine 2016;50(2):230‐5. [PUBMED: 26497261]

Deeks 2011

Deeks JJ, Higgins JPT, Altman DG. Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.

DeLancey 1988

DeLancey JOL. Anatomy and mechanics of structures around the vesical neck: how vesical position may affect its closure. Neurourology and Urodynamics 1988;7:161‐2.

Dumoulin 2018

Dumoulin C, Cacciari LP, Hay‐Smith EJC. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database of Systematic Reviews 2018, Issue 10. [DOI: 10.1002/14651858.CD005654.pub4; PUBMED: 30288727]

Egger 1997

Egger M, Smith GD, Schneider M, Minder C. Bias in meta‐analysis detected by a simple, graphical test. BMJ 1997;315(7109):629–34.

Guyatt 2011a

Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction ‐ GRADE evidence files and summary of findings tables. Journal of Clinical Epidemiology 2011;64(4):383‐94.

Guyatt 2011b

Guyatt GH, Oxman AD, Kunz R, Brozek J, Alonso‐Coello P, Rind D, et al. GRADE guidelines 6. Rating the quality of evidence ‐ imprecision. Journal of Clinical Epidemiology 2011;64(12):1283‐93.

Haylen 2010

Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. International Urogynecology Journal 2010;21(1):5‐26. [PUBMED: 19937315]

Herderschee 2011

Herderschee R, Hay‐Smith EJ, Herbison GP, Roovers JP, Heineman MJ. Feedback or biofeedback to augment pelvic floor muscle training for urinary incontinence in women. Cochrane Database of Systematic Reviews 2011, Issue 7. [DOI: 10.1002/14651858.CD009252; PUBMED: 21735442]

Hewitt 2001

Hewitt J. The Complete Yoga Book. New York: Schocken Books Inc, 2001.

Higgins 2011a

Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.

Higgins 2011b

Higgins JPT, Deeks JJ, Altman DG, editor(s). Chapter 16: Special topics in statistics. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.

Huang 2014b

Huang AJ, Jenny HE, Chesney MA, Schembri M, Subak LL. A group‐based yoga therapy intervention for urinary incontinence in women: a pilot randomized trial. Female Pelvic Medicine & Reconstructive Surgery 2014;20(3):147‐54. [PUBMED: 24763156]

Imamura 2015

Imamura M, Williams K, Wells M, McGrother C. Lifestyle interventions for the treatment of urinary incontinence in adults. Cochrane Database of Systematic Reviews 2015, Issue 12. [DOI: 10.1002/14651858.CD003505.pub5; PUBMED: 26630349]

Kim 2015

Kim GS, Kim EG, Shin KY, Choo HJ, Kim MJ. Combined pelvic muscle exercise and yoga program for urinary incontinence in middle‐aged women. Japan Journal of Nursing Science: JJNS 2015;12(4):330‐9. [PUBMED: 25705816]

Long 2008

Long RM, Giri SK, Flood HD. Current concepts in female stress urinary incontinence. Surgeon 2008;6(6):366‐72. [PUBMED: 19110826]

Lose 2001

Lose G, Fantl JA, Victor A, Walter S, Wells TL, Wyman J, et al. Outcome measures for research in adult women with symptoms of lower urinary tract dysfunction. Acta Obstetricia et Gynecologica Scandinavica 2001;80(11):981‐5. [DOI: 10.1034/j.1600‐0412.2001.801102.x]

Microsoft Excel 2018 [Computer program]

Microsoft Corporation. Microsoft Excel for Mac. Version 16.20. Redmond, WA, USA: Microsoft Corporation, 2018.

Miller 1998

Miller JM, Ashton‐Miller JA, DeLancey JO. A pelvic muscle precontraction can reduce cough‐related urine loss in selected women with mild SUI. Journal of the American Geriatrics Society 1998;46(7):870‐4. [PUBMED: 9670874]

Milsom 2017

Milsom I, Altman D, Cartwright R, Lapitan MC, Nelson R, Sjöström S, et al. Epidemiology of urinary incontinence (UI) and other lower urinary tract symptoms (LUTS), pelvic organ prolapse (POP) and anal (AI) incontinence. Incontinence: 6th International Consultation on Incontinence. Bristol UK: International Continence Society, 2017:5‐93. [ISBN: 978‐0‐9569607‐3‐3]

Minassian 2013

Minassian VA, Devore E, Hagan K, Grodstein F. Severity of urinary incontinence and effect on quality of life in women by incontinence type. Obstetrics and Gynecology 2013;121(5):1083‐90. [PUBMED: 23635747]

Moher 2009

Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta‐analyses: the PRISMA statement. PLoS Medicine 2009;6(7):e1000097.

Monz 2007

Monz B, Chartier‐Kastler E, Hampel C, Samsioe G, Hunskaar S, Espuna‐Pons M, et al. Patient characteristics associated with quality of life in European women seeking treatment for urinary incontinence: results from PURE. European Urology 2007;51(4):1073‐81; discussion 1081‐2. [PUBMED: 17081676]

Nystrom 2015

Nystrom E, Sjostrom M, Stenlund H, Samuelsson E. ICIQ symptom and quality of life instruments measure clinically relevant improvements in women with stress urinary incontinence. Neurourology and Urodynamics 2015;34(8):747‐51. [PUBMED: 25154378]

Park 2014

Park CL, Groessl E, Maiya M, Sarkin A, Eisen SV, Riley K, et al. Comparison groups in yoga research: a systematic review and critical evaluation of the literature. Complementary Therapies in Medicine 2014;22(5):920‐9. [PUBMED: 25440384]

Patrick 1999

Patrick DL, Martin ML, Bushnell DM, Yalcin I, Wagner TH, Buesching DP. Quality of life of women with urinary incontinence: further development of the incontinence quality of life instrument (I‐QOL). Urology 1999;53(1):71‐6. [PUBMED: 9886591]

Reference Manager 2012 [Computer program]

Thomson Reuters. Reference Manager Professional Edition. Version 12. New York: Thomson Reuters, 2012.

Review Manager 2014 [Computer program]

Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.

Sandvik 1993

Sandvik H, Hunskaar S, Seim A, Hermstad R, Vanvik A, Bratt H. Validation of a severity index in female urinary incontinence and its implementation in an epidemiological survey. Journal of Epidemiology and Community Health 1993;47(6):497‐9. [PUBMED: 8120507]

Shemilt 2011

Shemilt I, Mugford M, Byford S, Drummond M, Eisenstein E, Knapp M, et al. Chapter 15: Incorporating economics evidence. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.

Sinclair 2011

Sinclair AJ, Ramsay IN. The psychosocial impact of urinary incontinence in women. Obstetrician & Gynaecologist 2011;13(3):143‐8. [DOI: 10.1576/toag.13.3.143.27665]

Steers 2002

Steers WD. Pathophysiology of overactive bladder and urge urinary incontinence. Reviews in Urology 2002;4 Suppl 4:S7‐18. [PUBMED: 16986023]

Sterne 2011

Sterne JA, Sutton AJ, Ioannidis JP, Terrin N, Jones DR, Lau J, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta‐analyses of randomised controlled trials. BMJ (Clinical research ed.) 2011;343:d4002. [PUBMED: 21784880]

Taneja 2014

Taneja DK. Yoga and health. Indian Journal of Community Medicine 2014;39(2):68‐72. [PUBMED: 24963220]

Tenfelde 2014

Tenfelde S, Logan R, Abernethy M. Yoga from the pelvic floor. Beginnings (American Holistic Nurses' Association) 2014;34(1):24‐6. [PUBMED: 24683704]

Uebersax 1995

Uebersax JS, Wyman JF, Shumaker SA, McClish DK, Fantl JA. Short forms to assess life quality and symptom distress for urinary incontinence in women: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence Program for Women Research Group. Neurourology and Urodynamics 1995;14(2):131‐9. [PUBMED: 7780440]

Wallace 2004

Wallace SA, Roe B, Williams K, Palmer M. Bladder training for urinary incontinence in adults. Cochrane Database of Systematic Reviews 2004, Issue 1. [DOI: 10.1002/14651858.CD001308.pub2; PUBMED: 14973967]

Wieland 2013

Wieland LS, Manheimer E, Sampson M, Barnabas JP, Bouter LM, Cho K, et al. Bibliometric and content analysis of the Cochrane Complementary Medicine Field specialized register of controlled trials. Systematic Reviews 2013;2:51. [PUBMED: 23826877]

Wójtowicz 2014

Wójtowicz U, Plaszewska‐Zywko L, Stangel‐Wójcikiewicz K, Basta A. Barriers in entering treatment among women with urinary incontinence. Ginekologia Polska 2014;85(5):342‐7. [PUBMED: 25011214]

Referencias de otras versiones publicadas de esta revisión

Wieland 2017

Wieland LS, Shrestha N, Lassi ZS, Panda S, Chiaramonte D, Skoetz N. Yoga for treatment of urinary incontinence in women. Cochrane Database of Systematic Reviews 2017, Issue 5. [DOI: 10.1002/14651858.CD012668]

Characteristics of studies

Characteristics of included studies [ordered by study ID]

Baker 2014

Methods

Design: parallel randomised controlled trial

Country: USA

Setting: study run through university but location of intervention delivery (e.g. clinic, community yoga studio) not specified

Participants

30 women with urge‐predominant urinary incontinence

Types of incontinence: all women had urge‐predominant UI

Diagnostic criteria for incontinence: not specified

Severity and duration of incontinence: at baseline, the 3‐day average number of UI episodes for yoga participants was median 2.67 (range 1.67 to 6.33) and for MBSR participants was median 3.00 (1.67 to 9.33)

Age: yoga median age 58 (range 22 to 79) years; MBSR median age 59 (range 34 to 74) years

Pregnant/postpartum/menopausal status: "most were postmenopausal"

Weight: BMI range 20.34 to 36.15 kg/m²; yoga median 25.82 (range 20.90 to 36.15) kg/m²; MBSR median 26.15 (range 20.34 to 33.22) kg/m²
Recruitment: radio and newspaper within the community and poster advertisements at the university hospital, outpatient clinics and campus sites
Inclusion criteria: "[W]omen aged 18 years or older who had 5 or more UUI episodes, with urge predominance (urge >50% of total incontinent episodes), on a 3‐day voiding diary."
Exclusion criteria: "...anticholinergic medication use within 2 weeks of baseline assessments and past nonpharmacologic treatment of UUI such as supervised behavioral therapy, supervised or unsupervised physical therapy, supervised biofeedback transvaginal electrical stimulation, tibial nerve stimulation, sacral neuromodulation, and botulinum toxin bladder injections. Women were also excluded if they had a past diagnosis of painful bladder, interstitial cystitis, and/or neurological disorder.”

Interventions

Yoga group: 8 weekly yoga classes following "basic principles of yoga" and focusing on physical poses and relaxation. "Information was given on restorative yoga that emphasized the use of gravity, props, and floor poses for muscle relaxation. No education was given on breathing techniques in this yoga control program. Class time was also spent on education about the 7 chakras, self‐massage, and essential oils and how they can also assist in muscle relaxation."
Teacher(s): the classes were taught by a certified massage therapist/yoga instructor

Home practice: not described

Mindfulness‐based stress reduction (MBSR) group: 8 weekly group meetings following the traditional protocol of the Center for Mindfulness at the University of Massachusetts Medical Center. "The 8‐week MBSR program is a structured program that teaches participants a variety of meditation practices, mindful‐yoga, walking meditation, and discussions on the relationship between stress, illness, and health."

Teacher(s): the classes were taught by a licensed occupational therapist with teacher training in mindfulness‐based therapy

Home practice: women were given 'A Mindfulness‐Based Stress Reduction Workbook' and 15‐ to 30‐minute tapes to listen to. Women were asked to record instances of formal and informal techniques used in home practice sessions. "On average, the participants did a structured practice 5 times/wk (range, <1‐15.4 times/wk) and unstructured practice 9.7 times/wk (range, <1‐22 times/wk)."

Adherence to yoga and comparison interventions: 11/15 (73%) yoga participants and 13/15 (87%) MBSR participants completed at least 5 of 8 sessions

Common interventions: women were asked not to seek any other incontinence treatment while participating in the study. No women received any of the usual treatments of UUI, including bladder education, fluid management, or pelvic floor muscle exercises. None of the group sessions focused on bladder control.
Co‐interventions: no mention of included or excluded co‐interventions
Duration and follow‐up: interventions were provided for 8 weeks with follow‐up visits at 6 and 12 months

Number of withdrawals, with reasons: loss to follow‐up in the yoga group was 4/15 (27%) at 8 weeks, 5/15 (33.3%) at 6 months and 6/15 (40%) at 1 year. Loss to follow‐up in the MBSR group was 2/15 (13%) at 8 weeks, 5/15 (33.3%) at 6 months, and 3/15 (20%) at 1 year. It was not reported whether the women who did not complete follow‐up included withdrawals from treatment. Reasons for loss to follow‐up were not reported.

Outcomes

Participant report of continence or improvement. Patient Global Impression of Improvement (PGI‐I). Women self reported their overall impression of improvement, and the outcome was dichotomised as much better or very much better versus other responses. Information reported at 8 weeks, 6 months and 1 year.

Condition‐ or symptom‐specific quality of life. Overactive Bladder Health‐Related Quality of Life (OAB‐HRQL). The OAB‐HRQL score is obtained from summing the 13 items on the HRQL subscales of the Overactive Bladder Symptom and Health‐Related Quality of Life Questionnaire (OAB‐q). This score is transformed to a 0‐to‐100 scale in which higher scores reflect better quality of life. Median per cent change and IQR are reported at 8 weeks, 6 months and 1 year.

Quantification of symptoms: number of incontinence episodes. The 3‐day average of incontinence episodes was collected from a diary. Median per cent change and IQR are reported at 8 weeks, 6 months and 1 year.

Other measures of social or emotional impact of incontinence. Bothersomeness, as measured on the Overactive Bladder Symptom and Quality of Life‐Short Form (OABq‐SF). The score from this 6‐item scale is transformed to a 0‐to‐100 scale in which higher scores reflect greater bother and impact. Median per cent change and IQR are reported at 8 weeks, 6 months and 1 year.

Other outcomes collected: urge incontinence episodes, daytime voids, nighttime voids and pad use

Notes

Adverse events: no discussion of safety or adverse events
Measurement of expectations or treatment preferences at baseline: none
Unpublished data: Dr Jan Baker emailed LSW the statistical analysis report and details of the calculation and interpretation of the OAB‐HRQL and the OABq‐SF measures, including the questionnaire and scoring manual, on 27 September 2017. No unpublished baseline or outcome data were used in the review.
Funding: university and government. “This study was funded by an unrestricted grant from the University of Utah and was also supported by the University of Utah Study Design and Biostatistics Center, with funding in part from the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through grant 8UL1TR000105 (formerly UL1RR025764).”

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Randomisation was carried out by shuffling 'security tint' envelopes; the Cochrane Handbook for Systematic Reviews of Interventions indicates that shuffling envelopes corresponds to a low risk of bias for sequence generation. "Randomization was completed by block randomization at each of the 3 periods to maintain an equal number in each group. When an accurate count was obtained of women who signed the consent for participation in a group session, group assignments were placed in security envelopes and shuffled. Subjects were then allowed to pick an envelope. The envelope was opened in front of the research personnel and was noted on the randomization key along with the subjects’ study number. This randomization key was then placed in a sealed envelope. The randomization key was given to the data manager and was noted as either group 1 or group 2 on the data spread sheet. The statistician was given the randomization key."

Allocation concealment (selection bias)

Low risk

"When an accurate count was obtained of women who signed the consent for participation in a group session, group assignments were placed in security envelopes and shuffled. Subjects were then allowed to pick an envelope."

Blinding of participants and personnel (performance bias)
All outcomes

High risk

All participants and personnel were aware of the interventions being delivered. Study personnel may have been aware that MBSR was the intervention of interest and yoga considered an active control condition.

Blinding of outcome assessment (detection bias)
Symptom improvement and quality of life

Unclear risk

All outcomes were assessed by the participants themselves, who were not blinded to the interventions. However, since both interventions were active, it is unclear to what extent this may have biased outcome assessment.

Blinding of outcome assessment (detection bias)
Micturitions and incontinence episodes

Unclear risk

All outcomes were assessed by the participants themselves through diary entries, and the participants were not blinded to the interventions. However, since both interventions were active, it is unclear to what extent this may have biased outcome assessment.

Incomplete outcome data (attrition bias)
All outcomes

High risk

There were high rates of loss to follow‐up, and rates differed between groups. Loss to follow‐up in the yoga group was 4/15 (27%) at 8 weeks, 5/15 (33.3%) at 6 months, and 6/15 (40%) at 1 year. Loss to follow‐up in the MBSR group was 2/15 (13%) at 8 weeks, 5/15 (33.3%) at 6 months, and 3/15 (20%) at 1 year. Reasons for loss to follow‐up are not described.

Selective reporting (reporting bias)

Unclear risk

Study was registered and the primary and secondary outcomes from the trial registration are reported. However, only 2 of the secondary outcomes reported in the article are listed in the protocol.

Other bias

Low risk

Groups were comparable on baseline characteristics and the study appeared to be free of conflicts of interest related to funding.

Huang 2014a

Methods

Design: parallel randomised controlled trial

Country: USA

Setting: study run through university but location of intervention delivery (e.g. clinic, community yoga studio) not specified

Participants

19 women with either stress or urgency urinary incontinence

Types of incontinence: urgency‐predominant: all 12/19 (63%); yoga 6/10 (60%); control 6/9 (67%). Stress‐predominant: all 7/19 (37%); yoga 4/10 (40%); control 3/9 (33%).

Diagnostic criteria for incontinence: not specified

Severity and duration of incontinence: total incontinence episodes/day (based on 7‐day voiding diary) at baseline: yoga mean (SD) 2.77 (1.3); control mean (SD) 2.16 (1.2). Duration of incontinence not specified, but duration of 3 months or longer was an inclusion criterion.

Age: yoga mean (SD) age 60.5 (8.4) years; control mean (SD) age 62.4 (8.3) years.

Pregnant/postpartum/menopausal status: pregnancy in the last year was an exclusion criterion; menopausal status was not reported

Weight: yoga BMI mean (SD) 24.7 (2.7) kg/m²; control BMI mean (SD) 25.8 (3.8) kg/m²
Recruitment: "combination of newspaper advertisements, flyers posted in local community centers and businesses, and direct recruitment from clinician offices."
Inclusion criteria: "[W]omen had to be at least aged 40 years, report experiencing incontinence for at least 3 months, and document at least 7 episodes of incontinence on a screening 7‐day voiding diary, with at least half of those episodes being stress‐type or urgency‐type incontinence."
Exclusion criteria: "Women were excluded if they had severe mobility limitations that would prevent them from participating in a yoga therapy program (inability to walk up a single flight of stairs or at least 2 city blocks on level ground or an inability to stand up from a supine position unaided within 10 seconds) or if they reported formal yoga instruction within the past year or any prior use of yoga specifically to treat incontinence. Other exclusion criteria included pregnancy within the past 6 months; current urinary tract infection or hematuria (assessed by urine dipstick testing) or history of 3 or more urinary tract infections in the past year; major neurologic condition such as stroke, multiple sclerosis, or Parkinson disease; history of congenital defect leading to incontinence, fistula in the bladder or rectum, pelvic cancer or radiation, or interstitial cystitis or chronic pelvic pain; current symptomatic pelvic organ prolapse; body mass index greater than 35 kg/m2; or prior surgery to the urinary tract. Participants also could not have used practitioner‐supervised behavioral, pharmacological, or other clinical treatments (e.g. pessary) for incontinence within the past 3 months or be planning to initiate new clinical incontinence treatments during the study.”

Interventions

Yoga group: 90‐minute Iyengar yoga classes were provided twice per week for 6 weeks. The class focus was on physical poses and relaxation. "Tadasana (mountain
pose), Utkatasana (chair pose), Trikonasana (triangle pose), Malasana (squat pose), Viparita Karani Variation (legs up the wall pose), Salamba Set Bandhasana (supported bridge pose), Supta Baddha Konasana (reclined cobbler’s pose), and Savasana (corpse pose). While teaching these postures, instructors emphasized specific ways of practicing each posture to foster awareness of the pelvic floor structures and increase control over the pelvic floor muscles, in addition to improving general fitness and conditioning and promoting mindfulness, deep breathing, and relaxation."
Teacher(s): classes were taught by an experienced certified instructor and an assistant

Home practice: "Participants were also instructed to practice yoga at home for at least 1 additional hour per week and to record the dates and duration of practice in a home yoga diary. Participants were given a limited set of yoga props (mat, belt, and block) to take home and a manual with written descriptions and pictures depicting each of the key yoga postures featured in the classes. Tips on how to practice each posture safely and comfortably and how to adapt each posture to improve incontinence and pelvic floor function were also provided in the manual."

Wait‐list control group: "Women randomized to the control group did not attend group yoga therapy classes and were instructed to avoid outside yoga instruction for 6 weeks. At the end of the 6‐week study, control group participants were given a $180 gift certificate for yoga classes at a local yoga studio and a limited set of home yoga props (block, mat, and strap) to take home."

Adherence to yoga and comparison interventions: 9 (100%) women attended at least 1 group class, and 6/9 (67%) attended all group classes. 9 women (100%) completed at least 1 hour/week of home practice (self reported).

Common interventions: women were given a pamphlet with standard education and behavioural management strategies for incontinence
Co‐interventions: no mention of included or excluded co‐interventions
Duration and follow‐up: interventions were provided for 6 weeks, and there was a telephone call at 3 weeks and a clinic visit at 6 weeks

Number of withdrawals, with reasons: "After the randomization, but before the start of the yoga therapy program, 1 yoga therapy participant dropped out of the study citing worsened health." No other women in either group withdrew or were lost to follow‐up.

Outcomes

Participant report of continence or improvement. Overall satisfaction with change in urine leakage was measured on a 5‐point Likert scale, ranging from ‘‘very unsatisfied’’ to ‘‘very satisfied’’, dichotomised as "moderately satisfied" or more versus less than "moderately satisfied". Assessed at 6 weeks.

Condition‐ or symptom‐specific quality of life. “Incontinence Impact Questionnaire Short Form (IIQ‐7), a 7‐item measure of the impact of incontinence on physical activities, emotional health, travel, and social relationships.” The IIQ‐7 is measured on a scale from 0 to 100, with higher scores indicating more negative impact of incontinence upon activities, relationships and feelings. Mean (SD) of change is reported at 6 weeks.

Quantification of symptoms: number of micturitions. The mean episodes/day of voiding in the toilet, as measured on a 7‐day voiding diary. Mean (SD) of change is reported at 6 weeks.

Quantification of symptoms: number of incontinence episodes. The mean episodes/day of urinary incontinence, as measured on a 7‐day voiding diary. Mean (SD) of change is reported at 6 weeks.

Other measures of social or emotional impact of incontinence. Bothersomeness, as assessed on the Urogenital Distress Inventory 6 (UDI‐6) (a 6‐item questionnaire that assesses subjective bother associated with incontinence‐related symptoms). Scale is 0 to 100, with higher scores indicating more negative impact of incontinence upon activities, relationships and feelings. Mean (SD) of change is reported at 6 weeks.

Other outcomes collected: yoga adherence, yoga self efficacy, the Patient Perception for Bladder Condition (PPBC) ("a single‐item questionnaire assessing the degree to which participants consider their bladder condition to be a problem"), stress incontinence episodes/day, urgency incontinence episodes/day, daytime incontinence, nighttime incontinence, daytime voids and nighttime voids

Notes

Adverse events: “During a 3‐week telephone call and a 6‐week clinic visit, coordinators asked participants about any negative changes in their health and recorded any reported negative changes as adverse events on standardized forms. Adverse events were considered 'serious adverse events' if they met the standard definition of resulting in death, disability, or hospitalization. Participants were also encouraged to call study staff to report any negative changes in their health between scheduled calls or visits.”
Measurement of expectations or treatment preferences at baseline: none
Unpublished data: none
Funding: university/non‐profit. "This research was supported by a University of California San Francisco Osher Center for Integrative Medicine Pilot Award from the Mt Zion Health Fund." Investigators also report receiving support from the National Institutes of Health and the American Federation for Aging Research.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

“Eligible participants were randomly assigned by a computer in a 1:1 ratio to participate in a 6‐week group‐based yoga therapy program (yoga therapy group) or receive no yoga instruction for 6 weeks followed by a gift certificate for local yoga studio classes (control group). Randomization was stratified by incontinence type (stress or stress‐predominant vs urgency or urgency‐predominant).”

Allocation concealment (selection bias)

Unclear risk

Although randomisation was carried out by computer, the exact procedures surrounding allocation were unclear.

Blinding of participants and personnel (performance bias)
All outcomes

High risk

Participants and providers were aware of treatment assignment.

Blinding of outcome assessment (detection bias)
Symptom improvement and quality of life

High risk

Participants self reported symptom improvement, bothersomeness and quality of life. They were not masked to their treatment assignments and the control condition was an inactive, waiting‐list control.

Blinding of outcome assessment (detection bias)
Micturitions and incontinence episodes

Unclear risk

Participants recorded micturitions and incontinence episodes on 7‐day diaries, and the data were abstracted by masked assessors. However, since the participants were aware of treatment assignment, it is possible that this affected their assessment and recording of micturition and incontinence episodes.

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Attrition from yoga group at follow‐up was 10% (1/10), and there was no attrition from the control group.

Selective reporting (reporting bias)

Unclear risk

Study appears to be free of selective reporting. The primary outcome was prespecified in the trial registration, however none of the reported secondary outcomes are mentioned in the trial registration.

Other bias

Low risk

Although groups were different on the IIQ‐7 and in frequency of voiding in toilets at baseline, this is consistent with simple randomisation of a small sample. Funding is university, non‐profit and government, and there is no indication of researcher bias. First author was previously funded by pharma, which is disclosed.

BMI: body mass index
IQR: interquartile range
MBSR: mindfulness‐based stress reduction
SD: standard deviation
UI: urinary incontinence
UUI: urgency urinary incontinence

Characteristics of excluded studies [ordered by study ID]

Study

Reason for exclusion

Burgio 2003

Not an intervention of interest

Burgio 2006

Not an intervention of interest

Felsted 2017

Not an intervention of interest

Wein 2015

Not a primary study report (i.e. editorial about study)

Wells 1999

Not an intervention of interest

Characteristics of studies awaiting assessment [ordered by study ID]

Huang 2018

Methods

Design: parallel randomised controlled trial

Country: USA

Setting: study run through university but location of intervention delivery (e.g. clinic, community yoga studio) not specified

Participants

50 women with at least daily urinary incontinence

Types of incontinence: not reported

Diagnostic criteria for incontinence: not reported

Severity and duration of incontinence: not reported

Age: mean 65 (8) years (range 55 to 83 years)

Pregnant/postpartum/menopausal status: age greater than 50 was an inclusion criterion; menopausal status was not reported

Weight: not reported
Recruitment: not reported
Inclusion criteria: "[A]mbulatory women aged 50 years or older who reported at least daily UI, were not already engaged in yoga, and were willing to temporarily forgo using clinical UI treatments."
Exclusion criteria: not reported

Interventions

Yoga group: twice‐weekly Iyengar yoga classes were provided twice per week for 3 months. The class focus was on specialised Iyengar‐style yoga techniques.
Teacher(s): not reported

Home practice: once weekly
Stretching control group: "a non‐specific muscle stretching/strengthening program designed to provide a rigorous time‐and‐attention control for the yoga program."
Adherence to yoga and comparison interventions: 75% of women attended > 90% of group classes, and 88% of women completed > 90% of home practice hours. Adherence by group was not reported.

Common interventions: women were given a brief instruction and written information on behavioural management strategies for incontinence
Co‐interventions: no mention of included or excluded co‐interventions
Duration and follow‐up: interventions were provided for 3 months, and outcomes were assessed at 3 months after baseline

Number of withdrawals, with reasons: 6/56 (11%) of women withdrew. Withdrawals by group and withdrawal reasons were not reported.

Outcomes

Quantification of symptoms: number of incontinence episodes. Change in mean episodes of urinary incontinence; how this was measured is not reported. Data for decrease in total UI frequency in the 2 groups are provided, together with P value for comparison between groups, but this cannot be used in a data analysis because the number of participants in each group is unclear.

Other outcomes collected: not reported

Notes

Adverse events: no discussion of safety or adverse events
Measurement of expectations or treatment preferences at baseline: not reported
Unpublished data: Dr Margaret Chesney emailed LSW a submitted conference abstract on 1 December 2017
Funding: not reported. Trial registration states that sponsors and collaborators are University of California, San Francisco and the National Center for Complementary and Integrative Health.

UI: urinary incontinence

Data and analyses

Open in table viewer
Comparison 1. Yoga versus no specific active intervention

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Number of women who report cure or improvement of urinary incontinence (at short term ‐ 6 weeks) Show forest plot

1

18

Risk Ratio (M‐H, Fixed, 95% CI)

6.33 [1.44, 27.88]

Analysis 1.1

Comparison 1 Yoga versus no specific active intervention, Outcome 1 Number of women who report cure or improvement of urinary incontinence (at short term ‐ 6 weeks).

Comparison 1 Yoga versus no specific active intervention, Outcome 1 Number of women who report cure or improvement of urinary incontinence (at short term ‐ 6 weeks).

2 Urinary incontinence condition‐ or symptom‐specific quality of life (at short term ‐ 6 weeks) Show forest plot

1

18

Mean Difference (IV, Fixed, 95% CI)

1.74 [‐33.02, 36.50]

Analysis 1.2

Comparison 1 Yoga versus no specific active intervention, Outcome 2 Urinary incontinence condition‐ or symptom‐specific quality of life (at short term ‐ 6 weeks).

Comparison 1 Yoga versus no specific active intervention, Outcome 2 Urinary incontinence condition‐ or symptom‐specific quality of life (at short term ‐ 6 weeks).

3 Adjusted analysis for condition‐ or symptom‐specific quality of life at short term (6 weeks) Show forest plot

1

Mean Difference (Fixed, 95% CI)

‐27.7 [‐66.80, 11.40]

Analysis 1.3

Comparison 1 Yoga versus no specific active intervention, Outcome 3 Adjusted analysis for condition‐ or symptom‐specific quality of life at short term (6 weeks).

Comparison 1 Yoga versus no specific active intervention, Outcome 3 Adjusted analysis for condition‐ or symptom‐specific quality of life at short term (6 weeks).

4 Number of micturitions (daily) (at short term ‐ 6 weeks) Show forest plot

1

18

Mean Difference (IV, Fixed, 95% CI)

‐0.77 [‐2.13, 0.59]

Analysis 1.4

Comparison 1 Yoga versus no specific active intervention, Outcome 4 Number of micturitions (daily) (at short term ‐ 6 weeks).

Comparison 1 Yoga versus no specific active intervention, Outcome 4 Number of micturitions (daily) (at short term ‐ 6 weeks).

5 Adjusted analysis for number of micturitions at short term (6 weeks) Show forest plot

1

Mean Difference (Fixed, 95% CI)

‐0.12 [‐1.73, 1.49]

Analysis 1.5

Comparison 1 Yoga versus no specific active intervention, Outcome 5 Adjusted analysis for number of micturitions at short term (6 weeks).

Comparison 1 Yoga versus no specific active intervention, Outcome 5 Adjusted analysis for number of micturitions at short term (6 weeks).

6 Number of episodes of incontinence (daily) (at short term ‐ 6 weeks) Show forest plot

1

18

Mean Difference (IV, Fixed, 95% CI)

‐1.57 [‐2.83, ‐0.31]

Analysis 1.6

Comparison 1 Yoga versus no specific active intervention, Outcome 6 Number of episodes of incontinence (daily) (at short term ‐ 6 weeks).

Comparison 1 Yoga versus no specific active intervention, Outcome 6 Number of episodes of incontinence (daily) (at short term ‐ 6 weeks).

7 Adjusted analysis for number of incontinence episodes at short term (6 weeks) Show forest plot

1

Mean Difference (Fixed, 95% CI)

‐1.4 [‐2.79, ‐0.01]

Analysis 1.7

Comparison 1 Yoga versus no specific active intervention, Outcome 7 Adjusted analysis for number of incontinence episodes at short term (6 weeks).

Comparison 1 Yoga versus no specific active intervention, Outcome 7 Adjusted analysis for number of incontinence episodes at short term (6 weeks).

8 Bothersomeness of symptoms (at short term ‐ 6 weeks) Show forest plot

1

18

Mean Difference (IV, Fixed, 95% CI)

‐0.90 [‐1.46, ‐0.34]

Analysis 1.8

Comparison 1 Yoga versus no specific active intervention, Outcome 8 Bothersomeness of symptoms (at short term ‐ 6 weeks).

Comparison 1 Yoga versus no specific active intervention, Outcome 8 Bothersomeness of symptoms (at short term ‐ 6 weeks).

9 Adjusted analysis for bothersomeness of symptoms at short term (6 weeks) Show forest plot

1

Mean Difference (Fixed, 95% CI)

‐0.9 [‐1.40, ‐0.40]

Analysis 1.9

Comparison 1 Yoga versus no specific active intervention, Outcome 9 Adjusted analysis for bothersomeness of symptoms at short term (6 weeks).

Comparison 1 Yoga versus no specific active intervention, Outcome 9 Adjusted analysis for bothersomeness of symptoms at short term (6 weeks).

10 Adverse effects (at short term ‐ 6 weeks) Show forest plot

1

18

Risk Difference (M‐H, Fixed, 95% CI)

0.0 [‐0.38, 0.38]

Analysis 1.10

Comparison 1 Yoga versus no specific active intervention, Outcome 10 Adverse effects (at short term ‐ 6 weeks).

Comparison 1 Yoga versus no specific active intervention, Outcome 10 Adverse effects (at short term ‐ 6 weeks).

Open in table viewer
Comparison 2. Yoga versus an active intervention

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Number of women who report cure or improvement of urinary incontinence (at short term ‐ 8 weeks) Show forest plot

1

24

Risk Ratio (M‐H, Fixed, 95% CI)

0.09 [0.01, 1.43]

Analysis 2.1

Comparison 2 Yoga versus an active intervention, Outcome 1 Number of women who report cure or improvement of urinary incontinence (at short term ‐ 8 weeks).

Comparison 2 Yoga versus an active intervention, Outcome 1 Number of women who report cure or improvement of urinary incontinence (at short term ‐ 8 weeks).

2 Number of women who report cure or improvement of urinary incontinence (at intermediate term ‐ 6 months) Show forest plot

1

20

Risk Ratio (M‐H, Fixed, 95% CI)

0.2 [0.03, 1.42]

Analysis 2.2

Comparison 2 Yoga versus an active intervention, Outcome 2 Number of women who report cure or improvement of urinary incontinence (at intermediate term ‐ 6 months).

Comparison 2 Yoga versus an active intervention, Outcome 2 Number of women who report cure or improvement of urinary incontinence (at intermediate term ‐ 6 months).

3 Number of women who report cure or improvement of urinary incontinence (at long term ‐ 1 year) Show forest plot

1

21

Risk Ratio (M‐H, Fixed, 95% CI)

0.22 [0.03, 1.53]

Analysis 2.3

Comparison 2 Yoga versus an active intervention, Outcome 3 Number of women who report cure or improvement of urinary incontinence (at long term ‐ 1 year).

Comparison 2 Yoga versus an active intervention, Outcome 3 Number of women who report cure or improvement of urinary incontinence (at long term ‐ 1 year).

PRISMA study flow diagram.
Figuras y tablas -
Figure 1

PRISMA study flow diagram.

Study flow diagram for economics studies.
Figuras y tablas -
Figure 2

Study flow diagram for economics studies.

Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
Figuras y tablas -
Figure 3

Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.

Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
Figuras y tablas -
Figure 4

Risk of bias summary: review authors' judgements about each risk of bias item for each included study.

Comparison 1 Yoga versus no specific active intervention, Outcome 1 Number of women who report cure or improvement of urinary incontinence (at short term ‐ 6 weeks).
Figuras y tablas -
Analysis 1.1

Comparison 1 Yoga versus no specific active intervention, Outcome 1 Number of women who report cure or improvement of urinary incontinence (at short term ‐ 6 weeks).

Comparison 1 Yoga versus no specific active intervention, Outcome 2 Urinary incontinence condition‐ or symptom‐specific quality of life (at short term ‐ 6 weeks).
Figuras y tablas -
Analysis 1.2

Comparison 1 Yoga versus no specific active intervention, Outcome 2 Urinary incontinence condition‐ or symptom‐specific quality of life (at short term ‐ 6 weeks).

Comparison 1 Yoga versus no specific active intervention, Outcome 3 Adjusted analysis for condition‐ or symptom‐specific quality of life at short term (6 weeks).
Figuras y tablas -
Analysis 1.3

Comparison 1 Yoga versus no specific active intervention, Outcome 3 Adjusted analysis for condition‐ or symptom‐specific quality of life at short term (6 weeks).

Comparison 1 Yoga versus no specific active intervention, Outcome 4 Number of micturitions (daily) (at short term ‐ 6 weeks).
Figuras y tablas -
Analysis 1.4

Comparison 1 Yoga versus no specific active intervention, Outcome 4 Number of micturitions (daily) (at short term ‐ 6 weeks).

Comparison 1 Yoga versus no specific active intervention, Outcome 5 Adjusted analysis for number of micturitions at short term (6 weeks).
Figuras y tablas -
Analysis 1.5

Comparison 1 Yoga versus no specific active intervention, Outcome 5 Adjusted analysis for number of micturitions at short term (6 weeks).

Comparison 1 Yoga versus no specific active intervention, Outcome 6 Number of episodes of incontinence (daily) (at short term ‐ 6 weeks).
Figuras y tablas -
Analysis 1.6

Comparison 1 Yoga versus no specific active intervention, Outcome 6 Number of episodes of incontinence (daily) (at short term ‐ 6 weeks).

Comparison 1 Yoga versus no specific active intervention, Outcome 7 Adjusted analysis for number of incontinence episodes at short term (6 weeks).
Figuras y tablas -
Analysis 1.7

Comparison 1 Yoga versus no specific active intervention, Outcome 7 Adjusted analysis for number of incontinence episodes at short term (6 weeks).

Comparison 1 Yoga versus no specific active intervention, Outcome 8 Bothersomeness of symptoms (at short term ‐ 6 weeks).
Figuras y tablas -
Analysis 1.8

Comparison 1 Yoga versus no specific active intervention, Outcome 8 Bothersomeness of symptoms (at short term ‐ 6 weeks).

Comparison 1 Yoga versus no specific active intervention, Outcome 9 Adjusted analysis for bothersomeness of symptoms at short term (6 weeks).
Figuras y tablas -
Analysis 1.9

Comparison 1 Yoga versus no specific active intervention, Outcome 9 Adjusted analysis for bothersomeness of symptoms at short term (6 weeks).

Comparison 1 Yoga versus no specific active intervention, Outcome 10 Adverse effects (at short term ‐ 6 weeks).
Figuras y tablas -
Analysis 1.10

Comparison 1 Yoga versus no specific active intervention, Outcome 10 Adverse effects (at short term ‐ 6 weeks).

Comparison 2 Yoga versus an active intervention, Outcome 1 Number of women who report cure or improvement of urinary incontinence (at short term ‐ 8 weeks).
Figuras y tablas -
Analysis 2.1

Comparison 2 Yoga versus an active intervention, Outcome 1 Number of women who report cure or improvement of urinary incontinence (at short term ‐ 8 weeks).

Comparison 2 Yoga versus an active intervention, Outcome 2 Number of women who report cure or improvement of urinary incontinence (at intermediate term ‐ 6 months).
Figuras y tablas -
Analysis 2.2

Comparison 2 Yoga versus an active intervention, Outcome 2 Number of women who report cure or improvement of urinary incontinence (at intermediate term ‐ 6 months).

Comparison 2 Yoga versus an active intervention, Outcome 3 Number of women who report cure or improvement of urinary incontinence (at long term ‐ 1 year).
Figuras y tablas -
Analysis 2.3

Comparison 2 Yoga versus an active intervention, Outcome 3 Number of women who report cure or improvement of urinary incontinence (at long term ‐ 1 year).

Summary of findings for the main comparison. Yoga versus no specific active intervention

Yoga compared with wait‐list for urinary incontinence in women

Patient or population: women with either stress‐predominant or urge‐predominant urinary incontinence

Settings: community

Intervention: yoga

Comparison: wait‐list

Outcomes

Illustrative comparative risks* (95% CI)

Relative effect
(95% CI)

No. of participants
(studies)

Certainty of the evidence
(GRADE)

Comments

Assumed risk

Corresponding risk

Wait‐list

Yoga

Number of women who report they are cured (they no longer experience urinary incontinence)

The study did not report this outcome.

Number of women who report cure or improvement of urinary incontinence at short term (six weeks)

111 per 1000

703 per 1000
(160 to 1000)

RR 6.33 (1.44 to 27.88)

18
(1 study)

⊕⊝⊝⊝
very low1,2

Number of women who reported satisfaction with change in urine leakage.

Urinary incontinence condition‐ or symptom‐specific quality of life

at short term (6 weeks)

Measured by Incontinence Impact Questionnaire Short Form (IIQ‐7) (lower = better)

The mean change in the control group was a decrease of 31 units.

The mean change in the intervention group was 1.74 units higher (33.02 units lower to 36.50 units higher).

Not applicable

18
(1 study)

⊕⊝⊝⊝
very low1,2

Number of micturitions (daily)

at short term (6 weeks)

The mean change in the control group was a decrease of 0.13 micturitions.

The mean change in the intervention group was
0.77 fewer micturitions (2.13 fewer to 0.59 more).

Not applicable

18
(1 study)

⊕⊝⊝⊝
very low1,2

Number of episodes of incontinence (daily)

at short term (6 weeks)

The mean change in the control group was a decrease of 0.27 episodes.

The mean change in the intervention group was
1.57 fewer episodes (2.83 to 0.31 to fewer).

Not applicable

18
(1 study)

⊕⊝⊝⊝
very low1,2

Bothersomeness of symptoms

at short term (6 weeks)

Measured by Urogenital Distress Inventory 6 (UDI‐6) (lower = better)

The mean change in the control group was a decrease of 0.1 units.

The mean change in the intervention group was 0.90 units lower (0.34 to 1.46 lower).

Not applicable

18
(1 study)

⊕⊝⊝⊝
very low1,2

Adverse effects

at short term (6 weeks)

222 per 1000

222 per 1000
(0 to 600)

RD 0% (‐38% to 38%)

18
(1 study)

⊕⊝⊝⊝
very low1,2

2 women in each group reported an adverse effect. However, there were 7 adverse effects overall and the distribution of adverse effects between groups is not reported. None of the adverse effects were considered to be potentially related to the study and none were serious.

*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: confidence interval; RD: risk difference; RR: risk ratio

GRADE Working Group grades of evidence
High certainty: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate certainty: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low certainty: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low certainty: We are very uncertain about the estimate.

1Downgraded two levels for risk of bias because there was no blinding of participants or providers (risk of performance bias), and outcome was self assessed and self recorded by participants (risk of detection bias).
2Downgraded one level for imprecision (< 400 participants).

Figuras y tablas -
Summary of findings for the main comparison. Yoga versus no specific active intervention
Summary of findings 2. Yoga versus an active intervention

Yoga compared with mindfulness‐based stress reduction (MBSR) for urinary incontinence in women

Patient or population: women with urge‐predominant urinary incontinence

Settings: community

Intervention: yoga

Comparison: mindfulness‐based stress reduction (MBSR)

Outcomes

Illustrative comparative risks* (95% CI)

Relative effect
(95% CI)

No. of participants
(studies)

Certainty of the evidence
(GRADE)

Comments

Assumed risk

Corresponding risk

MBSR

Yoga

Number of women who report they are cured (they no longer experience urinary incontinence)

The study did not report this outcome.

Number of women who report cure or improvement of urinary incontinence

at short term (8 weeks)

461 per 1000

42 per 1000
(5 to 660)

RR 0.09 (0.01 to 1.43)

24
(1 study)

⊕⊝⊝⊝
very low1,2,3

Urinary incontinence condition‐ or symptom‐specific quality of life

at short term (8 weeks)

Measured by the Overactive Bladder Health‐Related Quality of Life (OAB‐HRQL) scale (higher per cent improvement = better)

⊕⊝⊝⊝
very low1,2,3

The study reported medians and IQR, therefore we could not extract data for meta‐analysis. The authors reported that the median per cent improvement at 8 weeks was 8.70 (IQR 1.75 to 20.59) in the yoga group (n = 11) and 29.27 (IQR 8.11 to 93.33) in the MBSR group (n = 13) (reported P value = 0.03).

Number of micturitions (daily)

The study did not report this outcome.

Number of episodes of incontinence (daily)

at short term (8 weeks)

⊕⊝⊝⊝
very low1,2,3

The study reported medians and IQR, therefore we could not extract data for meta‐analysis. The authors reported that the median per cent improvement at 8 weeks was ‐33.33 (IQR ‐50.00 to 16.67) in the yoga group (n = 11) and ‐60 (IQR ‐88.89 to ‐50.00) in the MBSR group (n = 13) (reported P value = 0.03).

Bothersomeness of symptoms

at short term (6 weeks)

Measured by the Overactive Bladder Symptom and Quality of Life‐Short Form (OABq‐SF) (lower = better)

⊕⊝⊝⊝
very low1,2,3

The study reported medians and IQR, therefore we could not extract data for meta‐analysis. The authors reported that the median per cent change at 8 weeks was ‐25.0 (IQR ‐35 to 20) in the yoga group (n = 11) and ‐55.6 (IQR ‐50 to ‐87) in the MBSR group (n = 13) (reported P value = 0.005).

Adverse effects

The study did not report on adverse effects.

*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: confidence interval; IQR: interquartile range; RR: risk ratio

GRADE Working Group grades of evidence
High certainty: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate certainty: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low certainty: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low certainty: We are very uncertain about the estimate.

1Downgraded two levels for risk of bias because there was no blinding of participants or providers (risk of performance bias), and there was a high percentage of loss to follow‐up that was unbalanced across study arms (risk of attrition bias).
2Downgraded one level for indirectness because the yoga intervention was not designed to treat urinary incontinence.
3Downgraded one level for imprecision (< 400 participants).

Figuras y tablas -
Summary of findings 2. Yoga versus an active intervention
Comparison 1. Yoga versus no specific active intervention

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Number of women who report cure or improvement of urinary incontinence (at short term ‐ 6 weeks) Show forest plot

1

18

Risk Ratio (M‐H, Fixed, 95% CI)

6.33 [1.44, 27.88]

2 Urinary incontinence condition‐ or symptom‐specific quality of life (at short term ‐ 6 weeks) Show forest plot

1

18

Mean Difference (IV, Fixed, 95% CI)

1.74 [‐33.02, 36.50]

3 Adjusted analysis for condition‐ or symptom‐specific quality of life at short term (6 weeks) Show forest plot

1

Mean Difference (Fixed, 95% CI)

‐27.7 [‐66.80, 11.40]

4 Number of micturitions (daily) (at short term ‐ 6 weeks) Show forest plot

1

18

Mean Difference (IV, Fixed, 95% CI)

‐0.77 [‐2.13, 0.59]

5 Adjusted analysis for number of micturitions at short term (6 weeks) Show forest plot

1

Mean Difference (Fixed, 95% CI)

‐0.12 [‐1.73, 1.49]

6 Number of episodes of incontinence (daily) (at short term ‐ 6 weeks) Show forest plot

1

18

Mean Difference (IV, Fixed, 95% CI)

‐1.57 [‐2.83, ‐0.31]

7 Adjusted analysis for number of incontinence episodes at short term (6 weeks) Show forest plot

1

Mean Difference (Fixed, 95% CI)

‐1.4 [‐2.79, ‐0.01]

8 Bothersomeness of symptoms (at short term ‐ 6 weeks) Show forest plot

1

18

Mean Difference (IV, Fixed, 95% CI)

‐0.90 [‐1.46, ‐0.34]

9 Adjusted analysis for bothersomeness of symptoms at short term (6 weeks) Show forest plot

1

Mean Difference (Fixed, 95% CI)

‐0.9 [‐1.40, ‐0.40]

10 Adverse effects (at short term ‐ 6 weeks) Show forest plot

1

18

Risk Difference (M‐H, Fixed, 95% CI)

0.0 [‐0.38, 0.38]

Figuras y tablas -
Comparison 1. Yoga versus no specific active intervention
Comparison 2. Yoga versus an active intervention

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Number of women who report cure or improvement of urinary incontinence (at short term ‐ 8 weeks) Show forest plot

1

24

Risk Ratio (M‐H, Fixed, 95% CI)

0.09 [0.01, 1.43]

2 Number of women who report cure or improvement of urinary incontinence (at intermediate term ‐ 6 months) Show forest plot

1

20

Risk Ratio (M‐H, Fixed, 95% CI)

0.2 [0.03, 1.42]

3 Number of women who report cure or improvement of urinary incontinence (at long term ‐ 1 year) Show forest plot

1

21

Risk Ratio (M‐H, Fixed, 95% CI)

0.22 [0.03, 1.53]

Figuras y tablas -
Comparison 2. Yoga versus an active intervention